MarketWatch14d
Dr. Reddy's Laboratories outperforms market on strong trading day
Shares of Dr. Reddy's Laboratories Ltd. 500124 rose 1.08% to 1,253.65 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index ...
cnbctv1814d
Kazakhstan fines Dr Reddy’s subsidiary ₹28.7 lakh for discontinuing some expense claims
Drug firm Dr Reddy’s Laboratories Ltd on Thursday (December 5) announced that its step-down wholly owned subsidiary, Dr Reddy's Laboratories Kazakhstan LLP, has received a penalty order from the ...
money.rediff14d
Dr Reddy's Unit Fined Rs 28.7 Lakh in Kazakhstan - PTI
Dr Reddy's Laboratories subsidiary in Kazakhstan has been fined Rs 28.7 lakh for disallowed expenses in 2021. The company says the penalty has no material impact on its financials. New Delhi, Dec 5 ...
Game Rant15d
Honkai: Star Rail – Current Banner, Next Banner, And Past Banners
When the three-week timer is over, players will see a change in the featured Warp Banner. Therefore, when a banner drops, Trailblazers have that much time to grind the game for every drop of ...
NDTV16d
Jagan Mohan Reddy
Ex-Andhra Pradesh Chief Minister Jagan Reddy has been accused of illegally acquiring 41.12 per cent of shares in Kakinada Seaport and 48.74 per cent in Kakinada Special Export Zone, for Rs 500 cr ...
MarketWatch21d
Dr. Reddy's Laboratories rises Friday, still underperforms market
Dr. Reddy's Laboratories Ltd. 500124 shares inched up 0.81% to 1,202.35 Indian rupees Friday, on what proved to be an all-around favorable trading session for the stock market, with the BSE SENSEX ...
Indiatimes21d
Ram Gopal Varma engages in fun banter with 'Animal' director Sandeep Reddy Vanga; asks him if he can make a better film than 'Baahubali'
Ram Gopal Varma and Sandeep Reddy Vanga had a candid chat, where Varma challenged Vanga on his filmmaking abilities, particularly about making Baahubali. Varma teased Vanga for his diplomatic ...
Indiatimes21d
Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinoma
In 2023, Dr Reddy's entered into a license and commercialisation agreement with Shanghai Junshi Biosciences Co Ltd for Toripalimab. Under this agreement, Dr Reddy's obtained exclusive rights to ...
cnbctv1821d
Dr. Reddy's launches India's only immuno-onco drug for a form of neck and head cancer
Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma ...
The Financial Express21d
Dr. Reddy’s launches first immuno-oncology drug to treat rare form of head and neck cancer in India
Dr. Reddy’s will market it under the brand name Zytorvi in India, it stated. “The standard of care for RM-NPC in India before Toripalimab was chemotherapy (gemcitabine and cisplatin).
Business Standard21d
Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India
Dr Reddy's Laboratories has announced the launch of Toripalimab ... the United States to receive access to this next generation PD-1 inhibitor. Dr. Reddys will market it under the brand name Zytorvi ...